- Home
- LMFA vs GDTC Comparison
LMFA vs GDTC Comparison
Compare LMFA & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMFA
- GDTC
- Stock Information
- Founded
- LMFA 2008
- GDTC 2018
- Country
- LMFA United States
- GDTC Singapore
- Employees
- LMFA N/A
- GDTC N/A
- Industry
- LMFA Finance: Consumer Services
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- LMFA Finance
- GDTC Health Care
- Exchange
- LMFA Nasdaq
- GDTC Nasdaq
- Market Cap
- LMFA 18.9M
- GDTC 21.5M
- IPO Year
- LMFA 2015
- GDTC 2023
- Fundamental
- Price
- LMFA $1.35
- GDTC N/A
- Analyst Decision
- LMFA Strong Buy
- GDTC Buy
- Analyst Count
- LMFA 1
- GDTC 1
- Target Price
- LMFA $5.00
- GDTC $5.00
- AVG Volume (30 Days)
- LMFA 596.1K
- GDTC 22.9K
- Earning Date
- LMFA 11-12-2025
- GDTC 01-01-0001
- Dividend Yield
- LMFA N/A
- GDTC N/A
- EPS Growth
- LMFA N/A
- GDTC N/A
- EPS
- LMFA N/A
- GDTC N/A
- Revenue
- LMFA $6,755,925.00
- GDTC $573,193.00
- Revenue This Year
- LMFA N/A
- GDTC $5.37
- Revenue Next Year
- LMFA $15.59
- GDTC N/A
- P/E Ratio
- LMFA N/A
- GDTC N/A
- Revenue Growth
- LMFA N/A
- GDTC 63.03
- 52 Week Low
- LMFA $1.02
- GDTC $1.65
- 52 Week High
- LMFA $5.14
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- LMFA 48.77
- GDTC 62.97
- Support Level
- LMFA $1.11
- GDTC $1.95
- Resistance Level
- LMFA $1.19
- GDTC $2.30
- Average True Range (ATR)
- LMFA 0.09
- GDTC 0.09
- MACD
- LMFA 0.05
- GDTC 0.01
- Stochastic Oscillator
- LMFA 61.76
- GDTC 70.29
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.